PERSIST-1

Trending/PERSIST-1

young cancer patient standing by window thinking

Targeted Drug Can ‘Diminish the Suffering’ of Myelofibrosis

CHICAGO — Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who…

No information found.

Sign up